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Objectives: To develop and validate a multiplex PCR-based
reverse line blot hybridization (mPCR/RLB) strategy for subtyp-
ing staphylococcal cassette chromosome mec (SCCmec) type IV
methicillin-resistant Staphylococcus aureus (MRSA) strains.
Methods: Sixty primer pairs and 63 probes were designed on
the basis of the available sequences of each open-reading frame
(ORF) at GenBank, for the previously described SCCmec IV sub-
types. Probes were compared in silico to 18 whole genome
sequences complete genome and partial SCCmec gene of 6 non-
MRSA strains, including methicillin susceptible S. aureus and
methicillin resistant coagulase negative staphylococci.
Results: The mPCR/RLB assay classiﬁed a set of 93 MRSA strains
which possessed SCCmec type IV into 68 subtypes, including 46
subtypes for 52 well-characterized reference strains and 22 sub-
types for 41 clinical strains. The discriminatory power (Simpson
indices of diversity of 0. 987) is higher than other genotyping
methods to date. It can rapidly and simultaneously detect 43
samples with a turn-around time (including culturing of isolates,
DNA extraction, mPCR setup and running, and RLB hybridization)
of about two working days. This comparative analysis the po-
tential sensitivity of probes demonstrated that each of the 63
probes found homologous match with at least one GenBank MRSA
SCCmec type IV sequence.
Conclusion: The application of mPCR/RLB hybridization assay to
MRSA SCCmec IV subtyping can improve the speciﬁcity, discrimi-
natory power and throughput of the typing procedure. Moreover
it is also a good tool for near-real time infection control surveil-
lance and MRSA transmission tracking.
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Early diagnosis and appropriate treatment of herpes virus in-
fections of pregnant women allows to minimize levels of inborn
herpes virus infections and fetal congenital defects.
Results of this pathology prenatal diagnostics often have am-
biguous and contradictory character. High levels of lethality and
fetal congenital defects incidence demand creation a complex of
diagnostic parameters for early stages of herpes virus infection
determination and fetal health status monitoring. Our aim was
to create complex of biochemical and immunological parameters
for amniotic ﬂuid investigation with the highest prognostic value
concerning inborn herpes virus infection and fetal congenital
defects incidence.
Materials and methods: Amniotic ﬂuid was obtained via trans-
abdominal amniocentesis from 24 pregnant women (18-35 years
old) with herpes virus infection (according virological analysis)
and fetal congenital defects (according to ultrasonic markers).
Antibidies IgM and IgG were determined by immunoenzymatic
analysis. Biochemical parameters were investigated on biochem-
ical analyzer “Cobas-Mira” (Austria).
Result: In ﬁrst group (10 women, 16-20 weeks gestation) there
were 1 positive result as to herpes virus IgG-antibidies, while in
second group (14 women, 21-24 weeks gestation) - 8. Changes in
biochemical parameters were statistically signiﬁcant even at 16
weeks of gestation. The highest changes were demonstrated for
levels of bilirubin, total protein, AST (increasing), glucose and
ALT (decreasing in comparison with norm).
Conclusions: Statistical analysis demonstrated that only complex
of biochemical, immunological, virological and ultrasonic inves-
tigations could have the highest prognostic value as to inborn
herpes virus infection and fetal congenital defects.
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Background: Based on the sequence variation in the N-terminus
of the UL55 gene, which encodes glycoprotein B (gB), human
cytomegalovirus (CMV) can be classiﬁed into four gBn genotypes.
This study determined the distribution and quantiﬁcation of CMV
gBn genotypes in a Chinese population of HSCT recipients and ex-
amined the correlations among the gBn genotype, pp65 antigen,
CMV gBn DNA, and clinical outcome.
Methods: The distribution of CMV gBn genotypes and the level of
gBn DNA were detected by real-time PCR.CMV-positive pp65 cells
were identiﬁed by immunohistochemical staining.
Result: The distribution of gB genotypes was as follows: gBn1,
60% of patients; gBn2, 13.3%; mixed gBn1 and gBn3 infection,
26.7%; and gBn4 and other mixed infections, 0%. The detected
level of CMV gB DNA correlated well with the number of CMV-
positive pp65 cells (r=0.514).
Conclusion: The distribution of CMV gBn genotypes in a Chinese
HSCT recipients were determined. And gBn1 genotype is predom-
inant. A statistical relationship between the different gB types
and the clinical outcome could be not determined, owing to the
small sample size in this study.
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Objective: To investigated the promoter methylation status of
IGF-II in hepatoma model and human HCC tissues for exploring its
mechanism at the occurrence of HCC.
Methods: Hepatoma models were induced with 2-FAA on male
SD rats. Morphological changes of livers were observed by H&E
staining. The CpG island methylation status of rat and human
IGF-II gene P was observed by MSP.
Results: IGF-II was overexpressed in hepatocytes from granule-
like degeneration to atypical hyperplasia and HCC development.
The levels of serum IGF-II expressions in HCC were signiﬁcantly
higher than any of other groups (P<0.01). The incidence of
P2 methylation was 100% in normal, 83.3% in degeneration,
11.1% in precancerous, and 0% in HCC group, respectively. The
rates of IGF-II P3 methylation in was 0% in human HCC, 47.5%
in their surrounding, and 100% in normal tissues, respectively,
with signiﬁcant differences among them (P=0.000). No signiﬁ-
cant signiﬁcance was found between the methylation rates of
IGF-II P3 and clinical parameters. However, the methylation
